Why we need a small data paradigm
- PMID: 31311528
- PMCID: PMC6636023
- DOI: 10.1186/s12916-019-1366-x
Why we need a small data paradigm
Abstract
Background: There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various 'big data' efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary 'small data' paradigm that can function both autonomously from and in collaboration with big data is also needed. By 'small data' we build on Estrin's formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit.
Main body: The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality.
Conclusion: Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved.
Keywords: Artificial intelligence; Data science; Personalized medicine; Precision health; Precision medicine; Small data.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Improving Outcomes through Personalised Medicine. Working at the cutting edge of science to improve patients’ lives. 2016. https://www.england.nhs.uk/wp-content/uploads/2016/09/improving-outcomes.... Accessed 10 Jun 2019.
-
- National Research Council (US) Committee on A Framework for Developing a New taxonomy of Disease . Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washington DC: National Academies Press; 2011. - PubMed
-
- The Precision Medicine Advisory Committee . Precision Medicine: An Action Plan for California. 2018.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
